An integrated mammalian library approach for optimization and enhanced microfluidics-assisted antibody hit discovery. Issue 1 (31st December 2023)

• Record Type: Journal Article
• Authors: Gaa, Ramona; Kumari, Kavita; Mayer, Hannah Melina; Yanakieva, Desislava; Tsai, Shang-Pu; Joshi, Saurabh; Guenther, Ralf; Doerner, Achim
• Is Part Of: Artificial cells, nanomedicine, and biotechnology. Volume 51:Issue 1(2023)
• Page Start: 74
• Page End: 82
• Publication Date: 2023-12-31
• Subjects: Mammalian libraries -- microfluidics -- antibodies -- manufacturability -- hit discovery; Artificial cells -- Periodicals; Nanotechnology -- Periodicals; Blood substitutes -- Periodicals; Tissue engineering -- Periodicals; Molecules -- Periodicals; Biotechnology -- Periodicals; 615.39
• DOI: 10.1080/21691401.2023.2173219
• Languages: English
• ISSNs: 2169-1401

Abstract

Abstract: Recent years have seen the development of a variety of mammalian library approaches for display and secretion mode. Advantages include library approaches for engineering, preservation of precious immune repertoires and their repeated interrogation, as well as screening in final therapeutic format and host. Mammalian display approaches for antibody optimization exploit these advantages, necessitating the generation of large libraries but in turn enabling early screening for both manufacturability and target specificity. For suitable libraries, high antibody integration rates and resulting monoclonality need to be balanced – we present a solution for sufficient transmutability and acceptable monoclonality by applying an optimized ratio of coding to non-coding lentivirus. The recent advent of microfluidic-assisted hit discovery represents a perfect match to mammalian libraries in secretion mode, as the lower throughput fits well with the facile generation of libraries comprising a few million functional clones. In the presented work, Chinese Hamster Ovary cells were engineered to both express the target of interest and secrete antibodies in relevant formats, and specific clones were strongly enriched by high throughput screening for autocrine cellular binding. The powerful combination of mammalian secretion libraries and microfluidics-assisted hit discovery could reduce attrition rates and increase the probability to identify the best possible therapeutic antibody hits faster.